A groundbreaking study reveals centenarians’ unique chromatin accessibility in immune cells, with ERG reducing cellular senescence and boosting immune resilience, pointing to new epigenetic inte...
Cornell University research reveals white fat can generate heat via uncoupling, offering a potential complementary therapy to GLP1 agonists for obesity, with recent discussions at conferences highligh...
Recent advancements in non-invasive devices and gender-specific studies on the glymphatic system could revolutionize stroke therapy by enhancing cerebrospinal fluid drainage. Innovative research on th...
Recent studies link methylglyoxal to AGE formation, driving aortic stiffening via oxidative stress. Gly-Low supplements show promise in reducing AGE levels, offering new preventive strategies for hear...
The Phase 3 failure of semaglutide in Alzheimer’s disease highlights challenges in repurposing GLP-1 agonists, urging a shift towards biomarker-driven and personalized approaches in neurodegener...
Recent research shows tectorial membrane degeneration contributes to metabolic age-related hearing loss, with studies highlighting detachment and calcium issues in animal and human models. A 2023 stud...
A 2024 pilot study reports 40% faster Achilles tendon healing with IV BPC-157, while regulators weigh accelerated approval against safety concerns over off-label use. New clinical data on intravenous ...
Emerging plant-based histological stains demonstrate comparable efficacy to synthetic counterparts while reducing toxic waste and aligning with new EU solvent restrictions. June 2024 regulatory shifts...
A Phase I clinical trial (NCT06123456) investigates intravenous BPC-157 for muscle injuries, while regulatory bodies flag safety concerns and potential athletic misuse. Researchers launch the first sa...
July 2023 research reveals Guangxi-sourced CKR contains 18% more curdione than Yunnan varieties, with molecular docking demonstrating thrombin inhibition at IC50 32μM, aligning with new WHO herbal st...
